pharma
May faces pressure for cross-party talks over NHS future
March 26, 2018Medical Communications, Sales and Marketing NHS, Theresa May, UK government, biotech, drugs, pharma, pharmaceutical
A group of close to 100 MPs have demanded that Theresa May set up a parliamentary commission to plot the …
GSK’s shingles vaccine secures EU and Japan approvals
March 26, 2018Sales and Marketing EU, Europe, GSK, Japan, Shingrix, pharma, shingles
GlaxoSmithKline has announced that its shingles vaccine Shingrix has secured approval in two new regions: in Europe, for the prevention …
Roche’s Tecentriq improves OS in first-line lung cancer
March 26, 2018Research and Development, Sales and Marketing Roche, biotech, drugs, lung cancer, pharma, pharmaceutical, tecentriq
Roche has revealed further data from its Phase 3, IMpower150 study, which showed that a combination of Tecentriq and Avastin, …
Top Ten most popular articles on Pharmafile.com this week
March 23, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Canada, Celgene, Lundbeck, Marijuana, Novartis, Roche, Vertex, brexit, cannabis, multiple sclerosis, neuroscience, pharma
As me move startlingly quickly towards Easter, it’s time for another Top Ten rundown. This week, Celgene surprised the industry …
Indivior rocked by loss of patent case
March 23, 2018Medical Communications, Sales and Marketing Alvogen, biotech, drugs, indivior, opioid, pharma, pharmaceutical
Indivior has been dealt a hammer blow after US District Court for the District of Delaware found in favour of …
Medical waste in India to hit 775.5 tonnes daily by 2022, study suggests
March 23, 2018Manufacturing and Production, Medical Communications India, medical waste, pharma
A new report has shed light on the worrying state of medicinal wastage in India, indicating that the levels of …
Lifestyle factors to blame for 38% of cancers
March 23, 2018Medical Communications Cancer, Cancer Research UK, UK government, biotech, drugs, pharma, pharmaceutical
A new study by Cancer Research UK has found that more than 135,500 cases of cancer every year in the …
GSK withdraws from running for Pfizer Consumer Health
March 23, 2018Medical Communications, Sales and Marketing GSK, Pfizer, Pfizer Consumer Health, biotech, drugs, pharma, pharmaceutical
GSK has announced that it has decided to pull out of the race to acquire Pfizer’s Consumer Health business, ending …
Promising drug for hormone therapy-resistant breast cancer enters human trials
March 22, 2018Research and Development TTC-352, breast cancer, chicago, pharma
A team of researchers at Chicago’s University of Illinois (UIC) have revealed that their promising drug which could prove an …
US “right to try” legislation passes after initial defeat
March 22, 2018Medical Communications, Research and Development, Sales and Marketing FDA, House of representatives, Right to try, US, pharma
The controversial and much-discussed “right to try” bill has been passed in the US House of Representatives, quickly rebounding after …
Regeneron-Alnylam team up to treat NASH
March 22, 2018Research and Development, Sales and Marketing Alnylam, Regeneron, biotech, drugs, nash, pharma, pharmaceutical
Coming on the back of a Regeneron research piece published in the New England Journal of Medicine, the company announced …
Bayer-Monsanto deal one step closer, after EU nod
March 22, 2018Sales and Marketing Bayer, EU, biotech, drugs, monsanto, pharma, pharmaceutical
The merger between Bayer and agricultural giant, Monsanto, is inching closer to completion after the EU Commission won EU antitrust …
Sun Pharma receives approval for first biologic drug
March 22, 2018Sales and Marketing Sun Pharma, biotech, drugs, pharma, pharmaceutical
The beginning of Sun Pharma’s diversification out of generic drugs is here and it’s a drug that MSD, known as …
Independent committee report seeks Brexit healthcare clarity
March 21, 2018Medical Communications, Research and Development ABPI, UK, biotech, brexit, drugs, pharma, pharmaceutical
An independent report, entitled Brexit – Medicines, Medical Devices and Substances of Human Origin and written by the Health and …
NICE turns down Dompe’s eye drops for rare eye condition over price concerns
March 21, 2018Manufacturing and Production, Research and Development, Sales and Marketing Dompe, NICE, cenegermin, neurotrophic keratitis, pharma, rare disease
NICE has announced that it has recommended against the use of Dompe’s recombinant human nerve growth factor eye drop therapy …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
